{"id":"https://openalex.org/W2321397391","doi":"https://doi.org/10.1097/00004714-200304000-00010","title":"Safety and Efficacy of Switching Psychiatric Patients from a Delayed-Release to an Extended-Release Formulation of Divalproex Sodium","display_name":"Safety and Efficacy of Switching Psychiatric Patients from a Delayed-Release to an Extended-Release Formulation of Divalproex Sodium","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2321397391","doi":"https://doi.org/10.1097/00004714-200304000-00010","mag":"2321397391","pmid":"https://pubmed.ncbi.nlm.nih.gov/12640219"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-200304000-00010","doi":"https://doi.org/10.1097/00004714-200304000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200304000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007537731","display_name":"Robert Lynn Horne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133999245","display_name":"University of Nevada, Las Vegas","ror":"https://ror.org/0406gha72","country_code":"US","type":"education","lineage":["https://openalex.org/I133999245"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert Lynn Horne","raw_affiliation_strings":["University of Nevada School of Medicine and Lake Mead Hospital, North Las Vegas, Nevada 89102, USA. lvismpresident@aol.com","University of Nevada School of Medicine and Lake Mead Hospital, North Las Vegas, Nevada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nevada School of Medicine and Lake Mead Hospital, North Las Vegas, Nevada 89102, USA. lvismpresident@aol.com","institution_ids":["https://openalex.org/I133999245"]},{"raw_affiliation_string":"University of Nevada School of Medicine and Lake Mead Hospital, North Las Vegas, Nevada","institution_ids":["https://openalex.org/I133999245"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033652829","display_name":"Cedric M. Cunanan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cedric Cunanan","raw_affiliation_strings":["Neuroscience Medical Liaison, Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Medical Liaison, Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007537731"],"corresponding_institution_ids":["https://openalex.org/I133999245"],"apc_list":null,"apc_paid":null,"fwci":3.203,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.91728469,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":"2","first_page":"176","last_page":"181"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.12540000677108765,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.03889999911189079,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/divalproex-sodium","display_name":"divalproex sodium","score":0.9909999966621399},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.9860000014305115},{"id":"https://openalex.org/keywords/delayed-release-formulation","display_name":"delayed-release formulation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/formulation-switching","display_name":"formulation switching","score":0.8759999871253967},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.7910000085830688},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9359999895095825},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.9869999885559082},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/intermittent-explosive-disorder","display_name":"intermittent explosive disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6159999966621399},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7720000147819519},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2908949014","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Divalproex","level":5,"score":0.6782382726669312},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.595089316368103},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.5800129175186157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49540889263153076},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.47425714135169983},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4451502561569214},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.4365713596343994},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.41691672801971436},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3741540312767029},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.354178249835968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33800777792930603},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.2395784556865692},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.1928688883781433},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.14374211430549622},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.11393013596534729}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-200304000-00010","doi":"https://doi.org/10.1097/00004714-200304000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200304000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12640219","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12640219","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2041034708","https://openalex.org/W2083020466","https://openalex.org/W2092753016","https://openalex.org/W2095305121","https://openalex.org/W2098644261","https://openalex.org/W2117556837","https://openalex.org/W2245911419","https://openalex.org/W2413120190","https://openalex.org/W4245997472"],"related_works":["https://openalex.org/W2020580472","https://openalex.org/W2093778598","https://openalex.org/W2132588848","https://openalex.org/W2113177593","https://openalex.org/W2004920311","https://openalex.org/W4223649033","https://openalex.org/W1966441141","https://openalex.org/W1967244685","https://openalex.org/W2077434827","https://openalex.org/W2123079645"],"abstract_inverted_index":{"This":[0,27,201],"study":[1,30,202],"evaluated":[2],"the":[3,69,99,111,128,145,181,214,232],"safety":[4],"and":[5,55,94,101,148,167,183,223],"efficacy":[6,95],"of":[7,62,86,185,189,234],"divalproex":[8,19,24,63,74,87,198,205],"sodium":[9,20,25,64,75,88,199,206],"extended-release":[10],"(ER)":[11],"when":[12],"patients":[13,33,56,125,175,191,219],"were":[14,53,92,108],"switched":[15],"from":[16,136,157],"therapy":[17,195],"with":[18,34,98,196,220],"delayed-release":[21],"(DR)":[22],"to":[23,81,138,159,193],"ER.":[26,200],"open-label,":[28],"7-day":[29],"included":[31],"55":[32,190],"bipolar":[35],"disorder,":[36,41],"major":[37],"depression,":[38],"schizophrenia,":[39],"schizoaffective":[40],"Alzheimer's":[42],"disease,":[43],"dementia,":[44],"or":[45],"intermittent":[46],"explosive":[47],"disorder.":[48],"Baseline":[49],"plasma":[50],"valproate":[51],"concentrations":[52,91,122],"determined,":[54],"received":[57,73],"their":[58,82],"usual":[59],"morning":[60],"dose":[61,79,85],"DR.":[65,89],"At":[66,172],"9:00":[67],"p.m.":[68],"same":[70],"day,":[71],"they":[72],"ER":[76,207,229],"at":[77,209],"a":[78,151,177],"equal":[80],"total":[83,168],"daily":[84],"Valproate":[90,121],"monitored,":[93],"was":[96,162],"measured":[97],"Positive":[100],"Negative":[102],"Syndrome":[103],"Scale":[104],"(PANSS).":[105],"Side":[106,117],"effects":[107],"assessed":[109],"using":[110],"Udvalg":[112],"for":[113,123,164,217],"Kliniske":[114],"Undersogelser":[115],"(UKU)":[116],"Effect":[118],"Rating":[119],"Scale.":[120],"52":[124],"remained":[126],"within":[127],"therapeutic":[129],"range.":[130],"Inpatient":[131],"PANSS":[132,169],"scores":[133],"significantly":[134],"improved":[135],"baseline":[137,158],"final":[139,160],"evaluation":[140,161],"on":[141],"all":[142],"subscales.":[143],"For":[144],"combined":[146],"inpatient":[147],"outpatient":[149],"populations,":[150],"small":[152],"but":[153],"statistically":[154],"significant":[155,178],"improvement":[156],"seen":[163],"positive,":[165],"general,":[166],"subscale":[170],"scores.":[171],"study's":[173],"end,":[174],"reported":[176],"decrease":[179],"in":[180],"number":[182],"severity":[184],"adverse":[186],"events;":[187],"54":[188],"elected":[192],"continue":[194],"once-daily":[197,235],"suggests":[203],"that":[204],"is":[208],"least":[210],"as":[211,213],"effective":[212],"DR":[215],"formulation":[216,230],"treating":[218],"psychiatric":[221],"illness":[222],"may":[224,238],"be":[225],"better":[226],"tolerated.":[227],"The":[228],"offers":[231],"advantage":[233],"dosing,":[236],"which":[237],"help":[239],"improve":[240],"compliance.":[241]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}